Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-29

FDA Approved: PYRIDOSTIGMINE BROMIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for pyridostigmine bromide submitted by Oceanside Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

SUPPL AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)